- Home
- SABS vs COCP Comparison
SABS vs COCP Comparison
Compare SABS & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SABS
- COCP
- Stock Information
- Founded
- SABS 2014
- COCP N/A
- Country
- SABS United States
- COCP United States
- Employees
- SABS N/A
- COCP N/A
- Industry
- SABS Biotechnology: Pharmaceutical Preparations
- COCP Biotechnology: Pharmaceutical Preparations
- Sector
- SABS Health Care
- COCP Health Care
- Exchange
- SABS Nasdaq
- COCP Nasdaq
- Market Cap
- SABS 19.0M
- COCP 20.1M
- IPO Year
- SABS N/A
- COCP N/A
- Fundamental
- Price
- SABS $1.82
- COCP $1.95
- Analyst Decision
- SABS Strong Buy
- COCP Strong Buy
- Analyst Count
- SABS 5
- COCP 1
- Target Price
- SABS $12.40
- COCP $7.00
- AVG Volume (30 Days)
- SABS 246.2K
- COCP 31.5K
- Earning Date
- SABS 03-28-2025
- COCP 03-27-2025
- Dividend Yield
- SABS N/A
- COCP N/A
- EPS Growth
- SABS N/A
- COCP N/A
- EPS
- SABS N/A
- COCP N/A
- Revenue
- SABS $1,512,723.00
- COCP N/A
- Revenue This Year
- SABS N/A
- COCP N/A
- Revenue Next Year
- SABS N/A
- COCP N/A
- P/E Ratio
- SABS N/A
- COCP N/A
- Revenue Growth
- SABS N/A
- COCP N/A
- 52 Week Low
- SABS $1.60
- COCP $1.35
- 52 Week High
- SABS $6.30
- COCP $3.26
- Technical
- Relative Strength Index (RSI)
- SABS 36.28
- COCP 47.95
- Support Level
- SABS $2.00
- COCP $1.75
- Resistance Level
- SABS $2.15
- COCP $2.08
- Average True Range (ATR)
- SABS 0.20
- COCP 0.20
- MACD
- SABS 0.03
- COCP 0.00
- Stochastic Oscillator
- SABS 30.99
- COCP 45.07
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.
About COCP Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first- and-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).